Dopamine agonists and the risk of cardiac-valve regurgitation by Schade René, Andersohn Frank, Suissa Samy, Haverkamp Wilhelm, Garbe Edeltraut in The New England journal of medicine (2007).

[PMID: 17202453] PubMed


Case reports and echocardiographic studies suggest that the ergot-derived dopamine agonists pergolide and cabergoline, used in the treatment of Parkinson's disease and the restless legs syndrome, may increase the risk of cardiac-valve regurgitation.

[ hide abstract ]

Discussed In Paper


Rx Annotations

No dosing information annotated.